Ticker Details
Anika Therapeutics Inc. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$291.48M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.45 | 2.14%
Avg Daily Range (30 D):	$0.55 | 2.94%
Avg Daily Range (90 D):	$0.43 | 2.66%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.08M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	97
Avg Trade Size (Sh.) (30 D):	45
Avg Trade Size (Sh.) (90 D):	38

Institutional Trades
Total Institutional Trades:	1,277
Avg Institutional Trade:	$1.24M
Avg Institutional Trade (30 D):	$1.44M
Avg Institutional Trade (90 D):	$.84M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.18M
Avg Closing Trade (30 D):	$1.18M
Avg Closing Trade (90 D):	$.82M
Avg Closing Volume:	33.49K

News

Jun 5, 2026 @ 9:00 PM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Na

Jan 26, 2026 @ 10:16 PM ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squir... Source: Bragar Eagel & Squire, P.C.

Dec 6, 2025 @ 1:00 AM Anika Therapeutics, Inc. INVESTIGATION: Kirby McIn... Source: Kirby Mcinerney Llp

Sep 25, 2025 @ 9:43 PM ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is... Source: Bragar Eagel & Squire, P.C.

Sep 5, 2025 @ 9:00 AM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Anika Therapeutics, Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.27	$.25	$-.38
Diluted EPS	$-.27	$.24	$-.37
Revenue	$120.65M	$32.61M	$29.61M
Gross Profit	$75M	$21.24M	$19M
Net Income / Loss	$-3.78M	$3.31M	$-5.06M
Operating Income / Loss	$-5.12M	$2.95M	$-5.49M
Cost of Revenue	$45.65M	$11.37M	$10.62M
Net Cash Flow	$-14.42M
PE Ratio